Andreas H. Groll

30.6k total citations · 3 hit papers
288 papers, 12.6k citations indexed

About

Andreas H. Groll is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Andreas H. Groll has authored 288 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Infectious Diseases, 196 papers in Epidemiology and 61 papers in Oncology. Recurrent topics in Andreas H. Groll's work include Antifungal resistance and susceptibility (185 papers), Fungal Infections and Studies (138 papers) and Neutropenia and Cancer Infections (48 papers). Andreas H. Groll is often cited by papers focused on Antifungal resistance and susceptibility (185 papers), Fungal Infections and Studies (138 papers) and Neutropenia and Cancer Infections (48 papers). Andreas H. Groll collaborates with scholars based in Germany, United States and Greece. Andreas H. Groll's co-authors include Thomas J. Walsh, Emmanuel Roilides, Thomas Lehrnbecher, Stephen C. Piscitelli, Rūta Petraitienė, Vidmantas Petraitis, Athanasios Tragiannidis, Markus Schneider, Christine C. Chiou and John Bacher and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andreas H. Groll

274 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital

1996 655 citations Andreas H. Groll et al. profile →
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

2011 540 citations Anna Skiada, Andreas H. Groll et al. profile →
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

2016 432 citations Γεώργιος Πετρίκκος, Andreas H. Groll et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas H. Groll Germany	59	9.6k	8.3k	1.8k	1.5k	1.2k	288	12.6k
Emmanuel Roilides Greece	62	10.7k 1.1×	9.3k 1.1×	1.3k 0.7×	1.8k 1.2×	1.3k 1.1×	432	15.8k
Monica A. Slavin Australia	55	7.5k 0.8×	7.3k 0.9×	2.6k 1.5×	1.2k 0.8×	854 0.7×	389	11.8k
Luis Ostrosky‐Zeichner United States	55	13.9k 1.4×	10.9k 1.3×	1.1k 0.6×	1.7k 1.1×	955 0.8×	211	17.3k
Russell E. Lewis United States	73	11.1k 1.2×	9.5k 1.1×	1.2k 0.7×	2.2k 1.5×	1.5k 1.2×	289	15.7k
William J. Steinbach United States	54	10.5k 1.1×	8.6k 1.0×	1.7k 1.0×	1.6k 1.1×	1.2k 1.0×	179	14.1k
Márcio Nucci Brazil	54	8.1k 0.8×	6.8k 0.8×	1.7k 1.0×	695 0.5×	804 0.7×	237	11.6k
José A. Vázquez United States	49	9.0k 0.9×	7.0k 0.8×	710 0.4×	1.0k 0.7×	537 0.4×	151	11.3k
Oliver A. Cornely Germany	72	16.5k 1.7×	14.2k 1.7×	3.2k 1.8×	1.5k 1.0×	1.6k 1.3×	546	21.3k
J. Peter Donnelly Netherlands	50	6.6k 0.7×	6.2k 0.8×	3.5k 2.0×	769 0.5×	937 0.8×	178	12.2k
S. A. Messer United States	75	15.2k 1.6×	12.0k 1.5×	860 0.5×	1.4k 0.9×	1.5k 1.2×	201	17.2k

Countries citing papers authored by Andreas H. Groll

Since Specialization

Citations

This map shows the geographic impact of Andreas H. Groll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas H. Groll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas H. Groll more than expected).

Fields of papers citing papers by Andreas H. Groll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas H. Groll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas H. Groll. The network helps show where Andreas H. Groll may publish in the future.

Co-authorship network of co-authors of Andreas H. Groll

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas H. Groll. A scholar is included among the top collaborators of Andreas H. Groll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas H. Groll. Andreas H. Groll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groll, Andreas H., et al.. (2025). Determination of Fluconazole in Children in Small Blood Volumes Using Volumetric Absorptive Microsampling (VAMS) and Isocratic High-Performance Liquid Chromatography–Ultraviolet (HPLC–UV) Detection. Pharmaceutics. 17(5). 592–592. 1 indexed citations

Müller, Carsten, et al.. (2024). Cerebrospinal fluid concentrations of posaconazole in paediatric leukaemia patients. Journal of Antimicrobial Chemotherapy. 79(3). 564–566.

Salmanton‐García, Jon, Michaela Simon, Andreas H. Groll, et al.. (2024). Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany. JAC-Antimicrobial Resistance. 6(3). dlae083–dlae083. 2 indexed citations

Rössig, Claudia, et al.. (2023). Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review. Transplant Infectious Disease. 25(2). e14028–e14028. 8 indexed citations

Ahlmann, Martina, et al.. (2022). Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients. Pediatric Drugs. 25(2). 225–232. 23 indexed citations

Gastine, Silke, Georg Hempel, Michael Neely, Thomas J. Walsh, & Andreas H. Groll. (2022). Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients. Journal of Antimicrobial Chemotherapy. 77(8). 2209–2216. 3 indexed citations

Lehrnbecher, Thomas, Andreas H. Groll, Simone Cesaro, et al.. (2022). Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009. Leukemia. 37(1). 72–78. 19 indexed citations

Kyriakidis, Ioannis, Elpis Mantadakis, Eftichia Stiakaki, Andreas H. Groll, & Athanasios Tragiannidis. (2022). Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. Cancers. 14(20). 5022–5022. 10 indexed citations

Zöllner, Stefan, et al.. (2021). Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma. Cancers. 13(9). 1990–1990. 7 indexed citations

10.

Lass‐Flörl, Cornelia, et al.. (2021). Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis. Journal of Antimicrobial Chemotherapy. 77(3). 695–698. 2 indexed citations

11.

Haeusler, Gabrielle M., Roland A. Ammann, Fabianne Carlesse, et al.. (2021). SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients. European Journal of Cancer. 159. 78–86. 29 indexed citations

12.

Kyriakidis, Ioannis, Eleni Vasileiou, Claudia Rössig, et al.. (2021). Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. Journal of Fungi. 7(3). 186–186. 26 indexed citations

13.

Gastine, Silke, William Hope, Georg Hempel, et al.. (2020). Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy. Antimicrobial Agents and Chemotherapy. 65(2). 10 indexed citations

14.

Ehlert, Karoline, Martina Ahlmann, Birgit Fröhlich, et al.. (2019). Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation. Mycoses. 63(2). 172–180. 22 indexed citations

15.

Tragiannidis, Athanasios, Martina Ahlmann, Birgit Fröhlich, et al.. (2019). Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10‐year experience at a European Pediatric Cancer Center. Mycoses. 62(10). 954–960. 9 indexed citations

16.

Zöllner, Stefan, О. В. Макарова, Thomas Kaiser, et al.. (2018). Durable control of hepatitis C through interferon‐free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantation. Journal of Viral Hepatitis. 26(4). 454–458. 2 indexed citations

17.

Groll, Andreas H., Robert Townsend, Amit Desai, et al.. (2017). Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transplant Infectious Disease. 19(5). 95 indexed citations

18.

Kyriakidis, Ioannis, Athanasios Tragiannidis, Ilse Zündorf, & Andreas H. Groll. (2017). Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses. 60(8). 493–507. 9 indexed citations

19.

Pana, Zoi Dorothea, Danila Seidel, Anna Skiada, et al.. (2016). Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infectious Diseases. 16(1). 667–667. 110 indexed citations

20.

Karthaus, Meinolf, Maria J. G. T. Rüping, Oliver A. Cornely, et al.. (2011). Current issues in the clinical management of invasive candida infections – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009. Mycoses. 54(5). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact